VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,206,000 | +52.7% | 180,986 | +4.6% | 0.00% | – |
Q1 2018 | $2,754,000 | -13.4% | 173,004 | +13.0% | 0.00% | – |
Q4 2017 | $3,180,000 | +44.8% | 153,117 | -0.1% | 0.00% | – |
Q3 2017 | $2,196,000 | +47.9% | 153,307 | +78.7% | 0.00% | – |
Q2 2017 | $1,485,000 | +42.1% | 85,799 | -9.4% | 0.00% | – |
Q1 2017 | $1,045,000 | -40.9% | 94,736 | -22.2% | 0.00% | – |
Q4 2016 | $1,767,000 | -50.4% | 121,700 | -16.2% | 0.00% | – |
Q3 2016 | $3,566,000 | +9.6% | 145,265 | -10.1% | 0.00% | – |
Q2 2016 | $3,253,000 | -2.4% | 161,545 | +27.5% | 0.00% | – |
Q1 2016 | $3,332,000 | -69.0% | 126,698 | +19.9% | 0.00% | -100.0% |
Q4 2015 | $10,745,000 | -3.5% | 105,698 | +69.3% | 0.00% | 0.0% |
Q3 2015 | $11,137,000 | -34.7% | 62,429 | -18.7% | 0.00% | -50.0% |
Q2 2015 | $17,059,000 | -6.9% | 76,792 | -16.7% | 0.00% | 0.0% |
Q1 2015 | $18,318,000 | +37.5% | 92,227 | -1.0% | 0.00% | +100.0% |
Q4 2014 | $13,325,000 | -23.9% | 93,118 | -30.2% | 0.00% | -50.0% |
Q3 2014 | $17,508,000 | +113.8% | 133,445 | +105.6% | 0.00% | +100.0% |
Q2 2014 | $8,189,000 | -57.7% | 64,917 | -55.8% | 0.00% | -50.0% |
Q1 2014 | $19,364,000 | +220.9% | 146,876 | +104.9% | 0.00% | – |
Q4 2013 | $6,034,000 | -89.5% | 71,684 | -87.0% | 0.00% | -100.0% |
Q3 2013 | $57,726,000 | +2219.2% | 553,310 | +1813.9% | 0.01% | – |
Q2 2013 | $2,489,000 | – | 28,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |